Binyam Bezabeh

1.4k total citations
14 papers, 898 citations indexed

About

Binyam Bezabeh is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Binyam Bezabeh has authored 14 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Binyam Bezabeh's work include Monoclonal and Polyclonal Antibodies Research (11 papers), HER2/EGFR in Cancer Research (7 papers) and Glycosylation and Glycoproteins Research (5 papers). Binyam Bezabeh is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), HER2/EGFR in Cancer Research (7 papers) and Glycosylation and Glycoproteins Research (5 papers). Binyam Bezabeh collaborates with scholars based in United States and France. Binyam Bezabeh's co-authors include Ryan Fleming, Nazzareno Dimasi, Changshou Gao, Herren Wu, Leslie Wetzel, Dorin Toader, R. James Christie, Jane Osbourn, Xinzhong Wang and Andy Q. Yuan and has published in prestigious journals such as Cancer Cell, Cancer Research and Journal of Controlled Release.

In The Last Decade

Binyam Bezabeh

13 papers receiving 841 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Binyam Bezabeh United States	11	529	476	382	93	91	14	898
Vaheh Oganesyan United States	19	722 1.4×	221 0.5×	755 2.0×	390 4.2×	35 0.4×	36	1.4k
Rajesh Vij United States	10	140 0.3×	265 0.6×	365 1.0×	104 1.1×	10 0.1×	13	726
Mitra Ahmadi France	16	267 0.5×	99 0.2×	288 0.8×	92 1.0×	14 0.2×	37	704
Christopher R. Behrens United States	11	240 0.5×	206 0.4×	294 0.8×	80 0.9×	76 0.8×	12	615
John Joosten Netherlands	12	180 0.3×	135 0.3×	405 1.1×	68 0.7×	287 3.2×	15	657
W L Cosand United States	17	238 0.4×	188 0.4×	441 1.2×	325 3.5×	58 0.6×	19	960
Venkata Ramana Doppalapudi United States	14	119 0.2×	102 0.2×	334 0.9×	54 0.6×	124 1.4×	21	626
Rebecca S.Y. Wong Canada	13	105 0.2×	381 0.8×	292 0.8×	251 2.7×	80 0.9×	17	741
Shuping Dou United States	18	457 0.9×	130 0.3×	303 0.8×	20 0.2×	87 1.0×	47	769
Jutta Schlepper‐Schäfer Germany	18	93 0.2×	113 0.2×	432 1.1×	211 2.3×	59 0.6×	26	873

Countries citing papers authored by Binyam Bezabeh

Since Specialization

Citations

This map shows the geographic impact of Binyam Bezabeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binyam Bezabeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binyam Bezabeh more than expected).

Fields of papers citing papers by Binyam Bezabeh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Binyam Bezabeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binyam Bezabeh. The network helps show where Binyam Bezabeh may publish in the future.

Co-authorship network of co-authors of Binyam Bezabeh

This figure shows the co-authorship network connecting the top 25 collaborators of Binyam Bezabeh. A scholar is included among the top collaborators of Binyam Bezabeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Binyam Bezabeh. Binyam Bezabeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Rios‐Doria, Jonathan, Jay Harper, Raymond Rothstein, et al.. (2017). Antibody–Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies. Cancer Research. 77(10). 2686–2698. 91 indexed citations

Dimasi, Nazzareno, Ryan Fleming, Haihong Zhong, et al.. (2017). Efficient Preparation of Site-Specific Antibody–Drug Conjugates Using Cysteine Insertion. Molecular Pharmaceutics. 14(5). 1501–1516. 59 indexed citations

Dimasi, Nazzareno, Ryan Fleming, Kris F. Sachsenmeier, et al.. (2017). Guiding bispecific monovalent antibody formation through proteolysis of IgG1 single-chain. mAbs. 9(3). 438–454. 5 indexed citations

Rios‐Doria, Jonathan, Jay Harper, Raymond Rothstein, et al.. (2017). Abstract 4596: Antibody-drug conjugates bearing pyrrolobenzodiazepine or tubulysin payloads alter the tumor immune microenvironment and synergize with multiple immunotherapies. Cancer Research. 77(13_Supplement). 4596–4596. 1 indexed citations

Christie, R. James, Arnaud Tiberghien, Qun Du, et al.. (2017). Pyrrolobenzodiazepine Antibody-Drug Conjugates Designed for Stable Thiol Conjugation. Antibodies. 6(4). 20–20. 17 indexed citations

Thompson, Pamela, Ian Hutchinson, Ryan Fleming, et al.. (2016). Straightforward Glycoengineering Approach to Site-Specific Antibody–Pyrrolobenzodiazepine Conjugates. ACS Medicinal Chemistry Letters. 7(11). 1005–1008. 28 indexed citations

Perry, Samuel R., Vanessa Muniz‐Medina, Xinzhong Wang, et al.. (2016). A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy. Cancer Cell. 29(1). 117–129. 292 indexed citations

Bezabeh, Binyam, Ryan Fleming, Christine Fazenbaker, et al.. (2016). Insertion of scFv into the hinge domain of full-length IgG1 monoclonal antibody results in tetravalent bispecific molecule with robust properties. mAbs. 9(2). 240–256. 16 indexed citations

Li, John, Dorin Toader, Samuel R. Perry, et al.. (2016). Abstract 2970: MEDI4276, a HER2-targeting antibody tubulysin conjugate, displays potent in vitro and in vivo activity in preclinical studies. Cancer Research. 76(14_Supplement). 2970–2970. 6 indexed citations

10.

Christie, R. James, Ryan Fleming, Binyam Bezabeh, et al.. (2015). Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides. Journal of Controlled Release. 220(Pt B). 660–670. 102 indexed citations

11.

Thompson, Pamela, Binyam Bezabeh, Ryan Fleming, et al.. (2015). Hydrolytically Stable Site-Specific Conjugation at the N-Terminus of an Engineered Antibody. Bioconjugate Chemistry. 26(10). 2085–2096. 24 indexed citations

12.

DiGiandomenico, Antonio, Ashley Keller, Cuihua Gao, et al.. (2014). A multifunctional bispecific antibody protects against Pseudomonas aeruginosa. Science Translational Medicine. 6(262). 262ra155–262ra155. 215 indexed citations

13.

Kimmel, Rhonda, Sharon E. Thomas, Gerald B. Pier, et al.. (2005). Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes. Vaccine. 23(25). 3264–3271. 28 indexed citations

14.

Garambois, Véronique, Elodie Foulquier, Marc Ychou, et al.. (2004). Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers. BMC Cancer. 4(1). 75–75. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact